Kyle R. Brimacombe
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 3
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 7
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 6
- Molecular Biology top 10%
- Biochemical and Molecular Research 4
-
- Amino Acid Enzymes and Metabolism 4
-
- Cell Image Analysis Techniques 4
-
- Pharmacological Effects and Toxicity Studies 4
- Co-authors
- Matthew D. HallMin ShenAnton SimeonovSamarjit PatnaikRichard T. EastmanJacob S. RothMichael M. GottesmanMatthew B. Boxer
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (2 papers)NeuroImage (1 paper)
- Partner nations
- United StatesSwedenCanada
In The Last Decade
Kyle R. Brimacombe
44 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Infectious Diseases 517
- Oncology 302
- Cancer Research 165
- Molecular Biology 742
- Computational Theory and Mathematics 163
Countries citing papers authored by Kyle R. Brimacombe
This map shows the geographic impact of Kyle R. Brimacombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle R. Brimacombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle R. Brimacombe more than expected).
Fields of papers citing papers by Kyle R. Brimacombe
This network shows the impact of papers produced by Kyle R. Brimacombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle R. Brimacombe. The network helps show where Kyle R. Brimacombe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kyle R. Brimacombe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 2 | |
| 3 | 2021 | 8 | |
| 4 | 2020 | 33 | |
| 5 | 2020 | 26 | |
| 6 | Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19breakdown → | 2020 | 654 |
| 7 | 2019 | 22 | |
| 8 | 2019 | 22 | |
| 9 | 2018 | 35 | |
| 10 | 2018 | 55 | |
| 11 | 2017 | 10 | |
| 12 | 2015 | 46 | |
| 13 | 2014 | 18 | |
| 14 | 2013 | 13 | |
| 15 | 2011 | 45 | |
| 16 | 2010 | 38 | |
| 17 | 2009 | 46 | |
| 18 | 2009 | 18 | |
| 19 | 2007 | 25 | |
| 20 | Development and Applications of the Bioassay Ontology (BAO) to Describe and Categorize High-Throughput Assays -- Assay Guidance Manual | 2004 | 3 |
About Kyle R. Brimacombe
Kyle R. Brimacombe is a scholar working on Biophysics, Biochemistry and Oncology, having authored 46 papers that have together received 1.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Cancer, Hypoxia, and Metabolism (6 papers), Amino Acid Enzymes and Metabolism (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Biochemical and Molecular Research (4 papers), Cell Image Analysis Techniques (4 papers), Pharmacological Effects and Toxicity Studies (4 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Infectious Diseases (517 citations), Oncology (302 citations) and Cancer Research (165 citations). Kyle R. Brimacombe has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include Matthew D. Hall, Min Shen, Anton Simeonov, Samarjit Patnaik, Richard T. Eastman, Jacob S. Roth, Michael M. Gottesman, Matthew B. Boxer, Andrea N. Ladd and Gary L. Griffiths. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and NeuroImage.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.